Next 10 |
home / stock / cor / cor articles
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 3.4% on an annualized basis producing an average annual return of 13.96%. ...
Koninklijke Philips (NYSE: PHG) recently announced the receipt of FDA 510(k) approval for its Zenition 30 mobile C-arm. The approval is likely to m...
Disclosed in a recent SEC filing on April 17, Collis, Chairman at Cencora (NYSE:COR), made a noteworthy transaction involving the exercise of compa...
Boston Scientific Corporation (NYSE: BSX) has been struggling due to unfavorable currency movement and macroeconomic woes. Strong competitors in th...
Cencora (NYSE:COR) has outperformed the market over the past 5 years by 13.84% on an annualized basis producing an average annual return of 26.68%....
Revealing a significant insider sell on March 20, Elizabeth S Campbell, Executive Vice President at Cencora (NYSE:COR), as per the latest SEC filin...
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 2.6% on an annualized basis producing an average annual return of 13.25%. ...
Cencora (NYSE:COR) has outperformed the market over the past 5 years by 11.43% on an annualized basis producing an average annual return of 24.09%....
The Federal Trade Commission (FTC) is reportedly launching an investigation into recent shortages of chemotherapies, including carboplatin, cisplat...
News, Short Squeeze, Breakout and More Instantly...
CoreSite Realty Corporation Company Name:
COR Stock Symbol:
NYSE Market:
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...
Revenue of $68.4 billion for the Second Quarter, a 7.8 Percent Increase Year-Over-Year Second Quarter GAAP Diluted EPS of $2.09 and Adjusted Diluted EPS of $3.80 Adjusted Diluted EPS Guidance Range Raised to $13.30 to $13.50 for Fiscal 2024 Cencora, Inc. (NYSE: COR) toda...
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 3.4% on an annualized basis producing an average annual return of 13.96%. ...